Flexion Therapeutics, Inc.
(NASDAQ : FLXN)

( )
FLXN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.43%89.631.3%$877.94m
AMGNAmgen Inc.
0.40%191.891.2%$550.47m
GILDGilead Sciences, Inc.
0.50%64.920.9%$461.62m
BIIBBiogen Inc.
-29.23%226.881.3%$457.10m
ONCESpark Therapeutics, Inc.
-0.20%113.2711.2%$443.03m
REGNRegeneron Pharmaceuticals, Inc.
-0.72%402.592.6%$280.51m
ILMNIllumina, Inc.
1.24%319.213.5%$280.06m
VRTXVertex Pharmaceuticals Incorporated
1.43%182.561.9%$232.81m
SRPTSarepta Therapeutics, Inc.
2.27%126.6615.4%$211.90m
EXASExact Sciences Corporation
1.70%92.0225.3%$191.93m
ALXNAlexion Pharmaceuticals, Inc.
1.94%134.212.0%$186.57m
BPTHBio-Path Holdings, Inc.
-14.05%18.48190.1%$182.12m
AAgilent Technologies, Inc.
1.34%82.001.6%$143.35m
IONSIonis Pharmaceuticals, Inc.
0.36%80.508.3%$105.13m
BMRNBioMarin Pharmaceutical Inc.
0.91%90.784.3%$95.05m

Company Profile

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick in 2007 and is headquartered in Burlington, MA.